Corneal neovascularization can be troublesome, especially in an eye which is to have a corneal graft. A corneal transplant is more likely to be rejected in a vascularized than a non-vascularized cornea. In this and many other clinical situations, therefore, it is desirable that corneal new vessels be obliterated. Many treatments have been suggested, including corticosteroids, irradiation, thiotepa, cryotherapy, photocoagulation, cysteine, chondroitin sulphuric acid, and dextran. One of us (PMHC) was, we believe, the first to report the use of the argon laser in the treatment of corneal neovascularization in man (Cherry, Faulkner, Shaver, Wise, and Witter, I1973). This was an open trial in four patients, two with chemical burns of the cornea and two with herpes simplex keratitis. There were two failures, one success, and one partial success. It was impossible to draw any definite conclusions from so few cases, and it was therefore decided to embark on a controlled trial in rabbits.
limbus and the other from the upper temporal limbus. Two sectors of vessels in the same eye were needed so that one could be used as a control and the other as the argon-treated area. The argon laser therapy was performed under sodium pentobarbitone anaesthesia and repeated at intervals of several days until the vessels were completely occluded. (Only one animal, no. 2, was killed before the treated vessels were occluded.
This was done deliberately to obtain some histological specimens very soon after argon laser treatment.)
The technique of laser therapy was as follows. Both arteries and veins were treated as they crossed the limbus and 2 to 3 mm to the corneal side of the limbus. The first treatment of each vessel was 'downstream' and the second 'upstream', thus trapping a column of blood which was able to absorb subsequent treatment of the vessel between these two points. Intravenous fluorescein was usually given immediately before the argon laser therapy so that more laser energy would be absorbed by the corneal vessels as they were being treated (Kohner, personal communication). Intravenous fluorescein was repeated during the treatment session to document the success or failure of each stage of the treatment. When the treated sector of corneal vessels was occluded the fluorescein angiograms were repeated at intervals of several days to make sure that the control vessels were still patent. The iris damage during the experiment was also documented with fluorescein angiography until the changes were stabilized. The instrument used for the argon laser therapy was manufactured by Coherent Radiation, Palo Alto, California, USA. The settings were usually 50 F.m spot size, 0-2 s exposure time, and I 50 mW energy (see Table) .
When the animals were killed their treated eyes were enucleated for histopathological study. Just before some of the animals were killed the pupil of the treated eye was dilated and the fundus examined with the indirect ophthalmoscope to determine if there was any visible retinal damage. No damage was found.
Results
The results are summarized in the fluorescent aqueous in the anterior chamber. The rabbit's other eye was used for comparison and there the entry of fluorescent aqueous into the anterior chamber via the pupil was much less. Three days after the application of the laser the amount of aqueous produced by the ciliary body was much less, and a week after the laser treatment it had returned to normal (Fig. io) . The focal iris leakage seen two to three hours after treatment (Figs 8, 9) had ceased. The corneal blood vessels seen in histological from many iris vessels including those at edge of black sections were generally in the superficial stroma patches (30 s post-injection) I960 The most obvious complication of argon laser therapy in these ii Dutch rabbits was damage to the iris. This must particularly be borne in mind because of the iris route of corneal graft rejection (Jones, I973) . If the argon laser is to be used extensively to occlude corneal new vessels in man we think it will be to occlude corneal new vessels before keratoplasty. Therefore if argon laser therapy to corneal vessels is complicated by an increased chance of corneal graft rejection by the iris route it must surely be discarded as a means of treating corneal new vessels in these circumstances. Black iris patches, 'shadows' of the treated corneal vessels, appeared immediately on treating the vessels in our Dutch rabbits and were caused by any laser energy not taken up by the corneal vessels.
Unger, Perkins, and Bass (I974) showed that laser irradiation of the iris in pigmented Dutch rabbits is followed by a transient increase in intraocular pressure of up to 45 mmHg within io minutes, with a return to normal within 2 hours. They suggested that this increase is mediated by E-type prostaglandins. They also found a breakdown of the blood-aqueous barrier with increased permeability to plasma proteins occurring in the ciliary processes and not in the iris. Fluorescein angiography performed in our experiment confirmed the findings by Unger and others (I974).
Angiograms two to three hours after the laser treatment showed no fluorescence through the surface black patches on the iris but there were focal dots of fluorescent leakage from many iris vessels, including those at the edge of the black patches (Figs 8, 9 ). This leakage persisted for a few days but had always resolved within a week. There was also massive outpouring of fluorescent aqueous from the ciliary processes, through the pupil, in the fluorescein angiograms two to three hours after laser treatment. The intraocular pressure was not measured at this time or immediately after laser treatment, but presumably it was transiently raised. The breakdown of the bloodaqueous barrier resolved slowly and was also back to normal within a week.
Histopathological examination of the iris lesions showed minute foci of stromal pigment disturbance which had given rise to tiny accumulations of melanin-laden macrophages near the anterior surface of the iris (Fig. i ic) . There was no sign of residual necrosis or inflammation and the pigment epithelium on the posterior surface of the iris was intact in every instance. This suggests that the iris damage stabilizes about one week after argon laser treatment of corneal blood vessels in pigmented Dutch rabbits and should not, therefore, necessarily contraindicate the use of the argon laser to treat corneal blood vessels in patients being considered for keratoplasty. 
